Page 21 – ORTHOWORLD

Paragon 28 Relies on Broad Portfolio to Offset Market Choppiness

The company grew in the high-teens in the third quarter of 2024, as its wide-ranging portfolio insulated it from market...

Nov 14, 2024, Mike Evers

Use cases for the system include hand and wrist, foot and ankle, sports medicine and pediatric applications....

Nov 14, 2024, Julie A. Vetalice

With these positive coverage updates, it is estimated that one-level lumbar TDR coverage is nearly 95% of the commercially-covered lives...

Nov 14, 2024, Julie A. Vetalice

Mid-tier growth companies Treace Medical, Paragon 28 and OrthoPediatrics are among the fastest-growing companies in orthopedics....

Nov 14, 2024, Mike Evers

The FDA clearance allows NovaBone Putty to be used in the intervertebral disc space alongside FDA-cleared interbody fusion devices....

Nov 13, 2024, Julie A. Vetalice

CITREPORE is a synthetic bioactive bone void filler composed of patented CITREGEN biomaterial technology....

Nov 12, 2024, Julie A. Vetalice

The company grew in the mid-single digits, driven by its broad product portfolio and increasing U.S. market penetration....

Nov 11, 2024, Mike Evers

Three founders share their journeys from starting companies to exiting to large orthopedic players....

Nov 11, 2024, Carolyn LaWell

Vertiwedge is the first intraosseous device designed to facilitate and maintain vertebral body correction of partially collapsed vertebrae....

Nov 08, 2024, Julie A. Vetalice

This additional funding will propel EpiBone's pipeline development of regenerative products for skeletal reconstruction....

Nov 08, 2024, Julie A. Vetalice